Medical Properties Trust Inc MPT
New risk paragraphs, branching off last year
Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Mar 3, 2025. A box jumps to the paragraph as filed, below.
Paragraphs with nothing like them in last year's 10-K
15 paragraphs in Risk Factors of the 10-K filed Feb 26, 2026 with nothing like them in the 10-K filed Mar 3, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
•adverse economic or operating conditions affecting our tenants could result in late payments, rent deferrals, restructurings or nonpayment, and could increase our costs for and the time required to re-tenant or sell affected properties, which could adversely affect our cash flows and results of operations.
management’s attention, cause us to incur increased professional fees that may not be recovered, and negatively impact our reputation and the market price of our common stock.
Companies across all industries have faced scrutiny related to their corporate responsibility practices and reporting. Certain investors, employees, and other stakeholders have focused on corporate responsibility practices and placed importance on the implications and broader societal impacts of their investments and business decisions. For example, some investment funds and certain institutional investors have previously incorporated aspects of corporate responsibility and sustainability (including third‑party scores) into stewardship, engagement, and, in some cases, investment or voting decisions, although these approaches vary and have shifted recently in response to market, regulatory, and political developments. Our failure, or perceived failure, to meet the goals and objectives we set in our sustainability disclosure, or to maintain accurate, consistent, and appropriately supported disclosures, could
negatively impact our reputation, tenant and employee retention, and access to capital. At the same time, in the U.S., corporate responsibility initiatives and disclosures have become increasingly politicized, including through anti‑environmental, social and governance (“ESG”) policy statements at the federal and state level, and legislative, regulatory, and enforcement initiatives in certain states. As a result, stakeholder expectations may be divergent, rapidly changing, and, in some cases, conflicting. Certain investors, lenders, counterparties, tenants, employees, and other stakeholders may seek greater corporate responsibility commitments and disclosure, while others may oppose or seek to limit corporate responsibility initiatives or the use of ESG‑related criteria in investment, lending, or contracting decisions as incompatible with fiduciary duties to maximize financial returns.
This evolving and polarized environment could adversely affect us in a number of ways, including by (i) increasing the cost and complexity of compliance and reporting as legal requirements, regulatory guidance, and market standards change, including as rules are proposed, modified, delayed, rescinded, or subject to litigation; (ii) exposing us to litigation, regulatory inquiries, or enforcement actions (including allegations of “greenwashing” or, conversely, claims that certain initiatives are impermissible or inconsistent with applicable law or fiduciary duties); and (iii) creating reputational risk, including the risk of negative publicity, activism, boycotts, or divestment from stakeholders on either side of these issues.
The terms of our Credit Facility and the indentures governing our outstanding senior notes and other debt instruments that we may enter into in the future are subject to customary financial, operational, and reporting covenants. For example, our Credit Facility imposes certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in
We have developed and constructed facilities in the past and are currently developing several facilities. Our development and related construction activities may subject us to a number of risks, including:
•our ability to complete construction is dependent on there being no title, environmental, or other legal proceedings in connection with the project;
•we may be subject to delays due to weather conditions, strikes, supply chain disruptions, available labor, and other contingencies beyond our control;
•we may be unable to obtain, or suffer delays in obtaining necessary zoning, land-use, building, occupancy, and other required governmental permits, which could result in increased costs, delays, or our abandonment of these projects; and
•we may incur construction costs for a facility which exceed our original estimates due to increased costs for materials or labor or other costs that we did not anticipate.
Show the other 4
Acquisitions and developments entail risks that investments will fail to perform in accordance with expectations and that cost estimates may prove inaccurate, as well as general investment risks associated with any new real estate investment. Newly-developed
equity investment in the operator, in addition to the effect on these tenants’/borrowers’ ability to meet their financial obligations to us, our ownership and investment interests may also be negatively impacted.
Certain states have enacted, and other states are considering, laws and regulatory regimes that seek to increase oversight of transactions involving REIT ownership or leasing of healthcare facilities. These measures include, among other things, prohibitions on certain sale-leaseback transactions involving acute-care hospitals; restrictions on the issuance of new hospital licenses for facilities leased from REITs; requirements that REIT investments be subject to enhanced transaction review and ongoing financial reporting obligations; and pre-transaction notice and review regimes applicable to certain healthcare transactions, including the sale, transfer, or lease of a material portion of a health care entity’s assets. Covered transactions may be subject to extended regulatory review periods, which could delay, condition, and/or increase the cost and complexity of completing such transactions. If these or similar regulatory restrictions are adopted more broadly, they could limit our ability to acquire and lease hospital properties, delay transactions, increase compliance costs, expose us to greater regulatory and legal risk, and adversely affect our business, results of operations, and financial condition.
information, such as in the event of cyber attacks. Further, our failure to protect the security of our information systems and data maintained in those systems could subject us to liability under various U.S. federal and state, and foreign privacy laws and regulations.
Paragraphs in the 10-Q filed Nov 6, 2026 that were not in the one before
New in the latest 10-Q
22 paragraphs in the 10-Q filed Nov 6, 2026 with nothing like them in the 10-Q filed Aug 10, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
Comprehensive income attributable to non-controlling interests (494) (280) (1,081) (828)
Read in the 10-Q
Comprehensive income (loss) attributable to MPT common stockholders $ 171,026 $ (128,811) $ 168,007 $ (45,403)
Read in the 10-Q
September 30, 2026 and 5,972 units at December 31, 2025 Limited Partners — issued and outstanding — 591,185 units at 4,472,112 4,393,915
Read in the 10-Q
Comprehensive income attributable to non-controlling interests (494) (280) (1,081) (828)
Read in the 10-Q
agreements, the fair value of our equity and loan investments, and the adequacy of our credit loss reserves on loans and financing receivables).
Read in the 10-Q
Show the other 17
either direct financing or other financing type leases. The components of our total investment in financing leases consisted of the following (in thousands):
Read in the 10-Q
2026 2025 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Minimum lease payments receivable $ 554,050 $ 570,150 Estimated unguaranteed residual values 203,818 203,818 Less: Unearned income and allowance for credit loss (505,413) (523,746) Net investment in direct financing leases 252,455 250,222 Other financing leases (net of allowance for credit loss) 131,964 171,462 Total investment in financing leases $ 384,419 $ 421,684 Other Leasing Activities At September 30, 2026, our vacant properties (with a net book value of approximately 4% of our total assets), including two developments (see "Development and Capital Addition Activities" above), are in various stages of being re-tenanted or sold. Our tenants’ financial performance and resulting ability to satisfy their lease and loan obligations to us are material to our financial results and our ability to service our debt and make distributions to our stockholders. Our tenants operate in the healthcare industry, which is highly regulated, and changes in regulation (or delays in enacting regulation) may temporarily impact our tenants’ operations until they are able to make the appropriate adjustments to their business. In addition, our tenants may experience operational challenges from time-to-time as a result of many factors, including those external to them, such as cybersecurity attacks, public health crises, economic issues resulting in high inflation and spikes in labor costs, extreme or severe weather and climate-related events, and adverse market and political conditions. We monitor our tenants' operating results and the potential impact from these challenges. We may elect to provide support to our tenants from time-to-time in the form of short-term rent abatements or rent deferrals to be paid back in full, or in the form of temporary loans. See below for an update on some of our tenants. Priory Group Effective July 1, 2026, we agreed to a lease amendment that included a cash rent reduction of approximately £11 million annually to Priory due to the decline in referrals over the past year or so by the National Health Service in the U.K. for the treatment of inpatient mental health services. This lease amendment also added a variable rent component to recapture some or all of the rent reduction if Priory were to reach certain revenue hurdles. We have also effectively extended the lease term by an additional ten years, and made certain other amendments to our lease and security agreements. This lease will continue to be classified as an operating lease and no material change is expected from a total revenue perspective. Scion/Lifepoint Transaction On June 1, 2026, we completed the Scion/Lifepoint Transaction which included (i) our acquisition of a new property from Lifepoint (as previously described in this same Note 3 under the "New Investments" subheading) in exchange for three Scion properties (as previously described in this same Note 3 under the "Disposals" subheading), (ii) the transition of hospital operations of two of our other facilities from Scion to Lifepoint, and (iii) the execution of a combined single master lease covering properties leased to Lifepoint and Lifepoint Behavioral. The new master lease has a lease term ending in 2045, annual cash rents approximating 99% of such rents prior to this transaction, and includes lease escalator provisions. The master lease is guaranteed by Lima Holdco, LLC and Springstone Health Opco, LLC, the parent companies of the individual lessees. Prospect In August 2019, we invested in a portfolio of 14 acute care hospitals in three states (California, Pennsylvania, and Connecticut) operated by and master leased to or mortgaged by Prospect Medical Holdings, Inc. ("Prospect") for a combined investment of approximately $1.6 billion. On May 23, 2023, Prospect completed a recapitalization plan, which included receiving $375 million in new financing from several lenders. Along with this new capital from third-party lenders, we agreed to the following restructuring of our then $1.7 billion investment including: a) maintaining the master lease covering six California hospitals without any changes in rental rates or escalator provisions, b) transitioning the Pennsylvania properties back to Prospect in return for a $150 million first lien mortgage, c) providing up to $75 million in a loan secured by a first lien on Prospect's accounts receivable and certain other assets, and d) obtaining a non-controlling ownership interest in PHP Holdings in exchange for unpaid rent and interest, among other things. Prospect filed for Chapter 11 bankruptcy on January 11, 2025 with the United States Bankruptcy Court for the Northern District of Texas. On March 20, 2025, the bankruptcy court approved a global settlement (including a recovery waterfall) between us, Prospect, and other stakeholders. Due to the bankruptcy, we recorded more than $400 million of impairment charges and negative fair
Read in the 10-Q
In regard to our investment in PHP Holdings, we accounted for this investment using the fair value option method. In the first nine months of 2025, we recorded an approximate $147 million negative fair value adjustment (none in the 2025 third quarter). The adjustment in 2025 was made based on changes to the purchase agreement between PHP Holdings and Astrana Health and updates to PHP Holdings' working capital position. On July 1, 2025, we received $2.3 million from the sale of PHP Holdings to Astrana Health.
Read in the 10-Q
As discussed in previous filings, we entered into agreements in September 2024 with six operators (HSA, Honor Health, Insight Health ("Insight"), Quorum, College Health, and Tenor Health ("Tenor")) to lease 18 of the 23 former Steward-operated facilities. Since then, we have sold and/or terminated the lease on six of the facilities. These leases included a cash rent ramp up period resulting in $26.4 million of cash rent received in the first nine months of 2025 ($12 million in the 2025 third quarter), compared to $76.4 million in the first nine months of 2026 ($22 million in the 2026 third quarter). As of mid-September 2026, the rent ramp up period has ended across all of these leases. As of September 30, 2026, all rents from these operators have been received, except for cash-basis operators Insight/Tenor who represent less than 1% of our annual revenues and HSA’s September rent of approximately $10 million.
Read in the 10-Q
As of September 30, 2026, we have approximately $175 million, net in working capital and other loans related to these operators that were initially advanced to assist in the takeover of these operations and the transition of certain services (such as revenue cycle management). These loans are generally secured by accounts receivables and/or other assets (including personal property). For HSA, we have advanced approximately $150 million in working capital loans through September 2026, including a net $12 million in the 2026 third quarter, as HSA continues to face revenue cycle management issues. In addition, approximately $9 million of working capital loans have been repaid from the other operators through September 30, 2026. For the working capital loans to Insight/Tenor, we have recorded charges of $30 million in the first nine months of 2026 ($3 million in the 2026 third quarter), which impaired these loans to equal the fair value of the underlying collateral.
Read in the 10-Q
Investments in Unconsolidated Entities Investments in Unconsolidated Real Estate Joint Ventures Our primary business strategy is to acquire real estate and lease to providers of healthcare services. Typically, we directly own 100% of such investments. However, from time-to-time, we will co-invest with other investors that share a similar view that hospital real estate is a necessary infrastructure-type asset in communities. In these types of investments, we will own undivided interests of less than 100% of the real estate through unconsolidated real estate joint ventures. The underlying real estate and leases in these unconsolidated real estate joint ventures are generally structured similarly and carry a similar risk profile to the rest of our real estate portfolio. The following is a summary of our investments in unconsolidated real estate joint ventures by primary operator (amounts in thousands): Operator Current As of September 30, As of December 31,
Read in the 10-Q
On an individual property basis, our largest investment in any single property was less than 2% of our total assets as of September 30, 2026.
Read in the 10-Q
On a revenue basis, concentration in 2026 compared to the same periods of 2025 is as follows:
Read in the 10-Q
Excludes the acquisition loan made in May 2020 related to our investment in the international joint venture, along with the related subsequent investment in the real estate of three hospitals in Colombia, as these assets are accounted for under the fair value option method, as noted below.
Read in the 10-Q
The remaining change from 2025 to 2026 primarily relates to a deferred tax benefit recognized in the 2025 third quarter in our MEDIAN joint venture from the lowering of German tax rates.
Read in the 10-Q
on September 16, 2026, we completed the sale of two facilities in Idaho to affiliates of Intermountain Health for gross proceeds of $371 million;
Read in the 10-Q
• entering into a new credit facility with a multi-year term. We plan to downsize the facility to a level more aligned with our current needs, which will create additional secured financing capacity for further refinancing activities noted below. We expect the covenant package on the new facility to give us greater flexibility to manage our capital structure as well;
Read in the 10-Q
• entering into a new credit facility with a multi-year term - see discussion above for details;
Read in the 10-Q
Risk Factors
Regulatory restrictions on healthcare REITs could adversely affect our business, results of operations, and financial condition.
Read in the 10-Q
Certain states have enacted, and other states are considering, laws and regulatory regimes that seek to increase oversight of transactions involving REIT ownership or leasing of healthcare facilities. These measures include, among other things, prohibitions on certain sale-leaseback transactions involving acute care hospitals; restrictions on the issuance of new hospital licenses for facilities leased from REITs; requirements that REIT investments be subject to enhanced transaction review and ongoing financial reporting obligations; and pre-transaction notice and review regimes applicable to certain healthcare transactions, including the sale, transfer, or lease of a material portion of a health care entity’s assets. Covered transactions may be subject to extended regulatory review periods, which could delay, condition, and/or increase the cost and complexity of completing such transactions. In addition, the Commonwealth of Massachusetts has recently passed legislation enabling, under certain conditions, the eminent domain taking of our replacement facility project in Norwood, Massachusetts (see “Development and Capital Addition Activities” subheading in Note 3 to the condensed consolidated financial statements). Although there is no certainty that the Commonwealth will pursue the taking of the Norwood facility, the Commonwealth’s eminent domain laws do require the payment of the fair market value of property as compensation. However, there is no certainty that such fair market value payment will be in line with our expectations, nor that it would be equal to or exceed our current net book value. Regardless of what the Commonwealth offers as compensation, Massachusetts law permits us to accept the compensation that is offered while retaining the right to seek additional compensation through an action filed with the Superior Court.
Read in the 10-Q
If these or similar regulatory restrictions are enforced by the different states, they could limit our ability to acquire and lease hospital properties, delay transactions, increase compliance costs, expose us to greater regulatory and legal risk, and adversely affect our business, results of operations, and financial condition.
Read in the 10-Q
Item 6
4.1 Indenture, dated as of August 10, 2026, by and among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., MPT Finance Corporation, the subsidiary guarantors party thereto, Wilmington Trust, National Association, as trustee and notes collateral agent (incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K of Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. filed with the Securities and Exchange Commission on August 10, 2026)
Read in the 10-Q
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 6, 2026 against Item 1A of the 10-K filed Feb 26, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:There have been no material changes to the Risk Factors as presented in our 2025 Annual Report, other than the following:
Read in the 10-Q
Phrases used for the first time
Two-word phrases in Risk Factors of the 10-K filed Feb 26, 2026 that are in none of the 1 earlier 10-Ks stored, back to Mar 3, 2025
Where each one is used
- hsa swiss: Our revenues are dependent upon our relationships with and success of our tenants, particularly our largest tenants, like Circle, Priory, HSA, Swiss Medical, and Lifepoint Behavioral.
- negative fair: We recorded real estate and other impairment charges along with negative fair value adjustments in 2024 and 2025 related to Steward and Prospect. For more information on these charges, see Note 3 to Item 8 of this Annual Report. We are dependent upon the ability of our tenants to make rent and loan payments to us,...
- value adjustments: We recorded real estate and other impairment charges along with negative fair value adjustments in 2024 and 2025 related to Steward and Prospect. For more information on these charges, see Note 3 to Item 8 of this Annual Report. We are dependent upon the ability of our tenants to make rent and loan payments to us,...
- substantial capital: We may incur substantial capital expenditures to make our healthcare facilities suitable for tenants or compliant with applicable regulatory requirements.
- enforcement actions: In addition, our tenants operate in the healthcare industry, which is highly regulated by U.S. federal, state, and local laws along with laws in Europe and South America and changes in applicable laws and regulations may temporarily impact our tenants’ operations until they are able to make the appropriate...
- leasing structures: We have made investments in certain operators of our healthcare facilities and the cash flows (and related returns) from these investments are subject to more volatility than our properties with traditional net leasing structures.
- cross-defaulted leases: Failure on the part of a tenant to comply materially with the terms of a lease could give us the right to terminate the lease, repossess the facility, cross default certain other leases and loans with that tenant, and enforce the payment obligations under the lease. The process of terminating a lease with a...
- properties across: Our employees are responsible for all aspects of managing our portfolio of over 380 properties across nine countries, and our failure to effectively manage our properties along with any growth may adversely impact our financial condition and cash flows, which could negatively affect our ability to service our debt...
Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.
What was taken out
12 paragraphs of last year's Risk Factors with nothing like them now. The longest are quoted.
Sources
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
Also
10-K change: what was reworded or cut, section by section.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MPT/export.csv") into a cell.